Profilo
Kari Myren is currently Chief Medical Officer at Oncoinvent ASA since 2021.
Former positions include Non-Executive Director at SoftOx Solutions AS, VP-Global Medical Affairs & Clinical Development at Photocure ASA from 2019 to 2021, and Chief Medical Officer at Oncoinvent ASA (Old).
Education includes an undergraduate degree from the University of Oslo.
Posizioni attive di Kari Myren
| Società | Posizione | Inizio |
|---|---|---|
| ONCOINVENT ASA | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
Precedenti posizioni note di Kari Myren
| Società | Posizione | Fine |
|---|---|---|
| SOFTOX SOLUTIONS | Direttore/Membro del Consiglio | 24/03/2023 |
| PHOTOCURE ASA | Direttore Tecnico/Scientifico/R&S | 01/10/2021 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Kari Myren
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
SoftOx Solutions AS
SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines | Commercial Services |
















